"The growth of a child is inspiring, wild, uncharted waters all at the same time....
Children animate and implore one to think and work outside of the box, play, imagine, and create."
Those are the words of Dr. Dennis Wall, founder of Cognoa and one of the world's top 25 autism researchers, per a press release.
He's also just been named to the Fierce 50, a list of the 50 most innovative people in the pharmaceutical, health care, and biotech industries, by Fierce Healthcare and Fierce Life Sciences.
"I am humbled and deeply grateful to be named a Fierce 50 honoree," Wall says in the press release.
"The one solution about which I am most excited is Canvas Dx, the first and only FDA-authorized autism diagnostic that uses responsible AI to empower doctors to facilitate quick, accurate, early answers and interventions for all kids."
Canvas Dx, which was approved by the FDA in October, is the first and only FDA-authorized developmental pediatric diagnostic that uses artificial intelligence to make diagnoses rapidly, objectively, fairly, and remotely so that children anywhere can get care during the ideal windows of development, before age 6.
It's used by general physicians and specialists alike and will help at least three million
A customized collection of grant news from foundations and the federal government from around the Web.
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.